BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Curia Unveils Comprehensive mRNA Solution

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today unveiled its messenger RNA (mRNA) solution, which incl...

December 27, 2021 | News

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developin...

December 20, 2021 | News

Antengene and XtalPi Announce AI-Driven R&D Collaboration

Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, global biopharmaceutical company dedicated to discovering, developing and ...

December 17, 2021 | News

GSK Announces Additional Supply of Monoclonal Antibody Sotrovimab to the SIngapore Govt.

GSK Singapore is contracted to supply the Government of Singapore with additional doses of sotrovimab, following the first purchase placed by t...

December 07, 2021 | News

Labcorp Completes Acquisition of Toxikon Corporation

-Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract res...

December 06, 2021 | News

Labcorp Completes Acquisition of Toxikon Corporation

-Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract res...

December 06, 2021 | News

10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year

10x Genomics (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced that Chromium X has been name...

December 02, 2021 | News

Sai Life Sciences’ pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan

Making the announcement, Krishna Kanumuri, CEO & Managing Director, said, "We are delighted to receive a formal Certificate of Inspection fro...

December 01, 2021 | News

Jubilant Biosys Limited Announces New Chemistry Innovation Research Center

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings.&n...

November 12, 2021 | News

Clinical Ink Acquires Digital Artefacts

Clinical Ink — a global clinical trial data and technology company and leader in eSource and decentralized clinical trial conduct — ...

November 08, 2021 | News

Catalent Further Expands Clinical Supply Network with New Facility in North America

The new facility marks the latest expansion to Catalent’s global clinical supply network, and follows the opening of a new site in Japan earlier this...

October 29, 2021 | News

Xcell Therapeutics opens an export route for cell therapy culture technology.

In a hair follicle, there are "dermal follicle papilla cells" that appear 3,000 grapes clustered together. The name was given because its outline resemble...

October 29, 2021 | News

Merck Drives New Innovation & Adds Capacity to Advance Next Generation (ADC) Therapies

Merck's unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges - New DOLCORE™ platform inc...

October 29, 2021 | News

Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®

Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...

October 26, 2021 | News

Stay Connected